Michael Tsaconas is BioCina’s Vice President and General Manager. Michael is a seasoned executive with more than 20 years experience in pharmaceutical manufacturing of liquids, creams, solid oral dose forms and large molecule drug substance at companies including FH Faulding, Mayne Pharma, Hospira and most recently Pfizer.
Michael has worked in the areas of Quality Control, Quality Assurance, Operational Excellence and Operations. He has had significant exposure to all aspects of Good Manufacturing Practice (GMP) and experience in the oversight of facilities that manufacture for highly regulated markets. Michael has been involved with manufacturing operations that have taken programs from development through to commercial manufacture. He was responsible for Pfizer’s Adelaide operations that achieved FDA approval for a biosimilar product in 2020.
Michael is a hands-on professional with a demonstrated strength and passion for change management and a strategic focus on building and supporting high performing teams to achieve business outcomes that generate value and growth.
Michael is from Adelaide, Australia and holds a Bachelor of Science (Hons) from Flinders University.